Plus Therapeutics Inc. (PSTV) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Plus Therapeutics Inc.

    NASDAQ: PSTV · Real-Time Price · USD
    0.49
    -0.02 (-3.01%)
    At close: Aug 27, 2025, 3:59 PM

    Plus Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -12.98M -13.32M -20.27M -13.4M
    Depreciation & Amortization
    		 723K 628K 619K 395K
    Stock-Based Compensation
    		 550K 569K 606K 606K
    Other Working Capital
    		 -909K 2.56M -855K -496K
    Other Non-Cash Items
    		 -2.07M 384K 481K 880K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 3.22M -1.12M 5.6M 1.24M
    Operating Cash Flow
    		 -10.55M -12.85M -12.97M -10.28M
    Capital Expenditures
    		 -146K -160K -509K -144K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -15.59M n/a n/a n/a
    Sales Maturities Of Investments
    		 12.17M n/a n/a n/a
    Other Investing Acitivies
    		 -545K n/a -250K 62K
    Investing Cash Flow
    		 -4.11M -160K -759K -82K
    Debt Repayment
    		 -704K -1.61M -1.61M -276K
    Common Stock Repurchased
    		 -374K -126K n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a -348K -773K 2.02M
    Financial Cash Flow
    		 6.19M 3.44M 13.45M 20.42M
    Net Cash Flow
    		 -8.48M -9.57M -280K 10.05M
    Free Cash Flow
    		 -10.7M -13.01M -13.48M -10.42M

    Add to Watchlist